Seven dogs with Spirocerca lupi esophageal granulomas were identified based
on the site of involvement (ie, distal esophagus) and characteristic endos
copic appearance. Six dogs presented with signs of esophageal disease and 1
dog was asymptomatic. Ova were only identified in the feces of 2 dogs. On
thoracic radiographs, 4 dogs had evidence of a caudodorsal mediastinal mass
, and 2 of these dogs had spandylitis of midthoracic vertebrae. On endoscop
y, single esophageal nodules were observed in 5 dogs, 1 dog had 3 nodules,
and 1 dog had 6 nodules. All 7 dogs were treated with doramectin at a dosag
e of 200 mug/kg SC at 14-day intervals for 3 treatments. Dogs had physical
and endoscopic examinations at 2, 4, and 6 weeks after treatment. By 6 week
s, clinical signs had resolved in 6 dogs (1 dog was asymptomatic), and the
esophageal nodules had completely resolved in 4 dogs, and incompletely reso
lved in 3 dogs. Two dogs with incomplete resolution were treated again with
doramectin at 500 mug/kg PO daily for an additional 6 weeks. Complete reso
lution of the esophageal nodules was confirmed by endoscopy in all dogs. No
dules had resolved in 4 dogs by 6 weeks, in 2 dogs by 12 weeks (after 6 wee
ks additional daily oral therapy), and in 1 dog 22 months after the initial
200 mug/kg treatment regimen. No dog experienced adverse effects to the dr
ug, and all symptomatic dogs have been free of disease for periods ranging
from 3 to 4 years.